Immunological Studies with Group B Arthropod-Borne Viruses

II. Effect of Prior Infection with Japanese Encephalitis Virus on the Viremia in Human Subjects Following Administration of 17D Yellow Fever Vaccine

Benjamin H. Sweet
Search for other papers by Benjamin H. Sweet in
Current site
Google Scholar
PubMed
Close
,
Charles L. Wisseman Jr.
Search for other papers by Charles L. Wisseman Jr. in
Current site
Google Scholar
PubMed
Close
,
Masami Kitaoka
Search for other papers by Masami Kitaoka in
Current site
Google Scholar
PubMed
Close
, and
Takeo Tamiya
Search for other papers by Takeo Tamiya in
Current site
Google Scholar
PubMed
Close
Restricted access

Summary

The incidence of viremia following vaccination with the 17D strain of yellow fever virus did not differ appreciably in a group of human subjects possessing prevaccination Japanese encephalitis neutralizing antibodies as a result of previous inapparent natural infection from the incidence of viremia in control groups possessing no prevaccination Group B arbor virus antibodies. There may have been a slight diminution in the level of circulating virus among the subjects with prevaccination JE neutralizing antibodies as compared with the level in the control groups; however, the number of uncontrolled factors which may have influenced these measurements precludes a firm conclusion on this matter.

Author Notes

Present address: Merck Institute for Research, West Point, Pennsylvania.

Save